Jewell Blackwell has joined Phynova, a British life science company, as its marketing and sales manager.

Phynova’s lead ingredient, reducose, is supported by more than 10 human clinical studies which provide evidence that it may reduce postprandial blood glucose and insulin levels.

Jewell joined the team to help provide wellness brands and their consumers with a low-dose, fast-acting wellness ingredient. “Reducose is a product that can help my loved ones live a healthier lifestyle, that’s convenient and efficacious. Being able to connect with a product on such a personal level makes going to work motivating and meaningful. Almost like a healthy sugar high, without the crash of course,” said Blackwell.

“Increasingly, consumers are recognizing that metabolic health is key not only for long-term health, but also for short-term health they can feel. The foundational benefits of glucose and insulin control provided by Reducose can play a role in supporting energy levels, cognitive health, sleep quality, and even satiety. Jewell’s ability to build a creative and consumer-focused environment that is grounded in science will be instrumental to help our customers position their products optimally in the market,” said Loick Fenaux, vice president of business development.